August 10, 2026

• Public Meeting on the Reauthorization of Generic Drug User Fee Amendments (GDUFA)

August 6, 2026

• FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab for melanoma
• September 23 Webinar: Communicating Drug Interaction and QTc Information in the U.S. Prescribing Information

This report displays final approvals and tentative approvals of original and supplemental applications for the two days beginning on the earliest date listed below. Some approvals may be added to the Drugs@FDA database after this time span. For comprehensive approval reports, please use the monthly "All Approvals" report on Drugs@FDA.